A Randomized Trial of Dose Escalation in definitive Chemoradiotherapy for patients with Oesophageal cancer *ART DECO*

Phase 3

Completed

• Conditions: esophagus cancer; Oesophageal cancer; 10017990

• Registration Number: NL-OMON41614
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 260

Inclusion Criteria

T1-4, N0-3, M0 adeno- or squamous cell carcinoma of the esophagus or esophageal gastric junction referred for definitive chemoradiation

Exclusion Criteria

tumors > 10 cm, unfit for definitive chemoradiation, pathologic lymphnodes at both truncus coeliacus and supraclavicular level, esophageal stent in situ.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>local tumor control</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>survival, toxicity</p><br>